PEW: With Opioid Crisis, a Surge in Hepatitis C

In a new “Stateline” article, Pew Charitable Trusts explores how the opioid epidemic is producing a surge in new hepatitis...

Sep 01, 2017 | Kim Rodgers

  • Fact Sheet: Reducing Harms from Injection Drug Use & Opioid Use Disorder with SSPs

    The Centers for Disease Control and Prevention’s (CDC’s) Division of HIV/AIDS Prevention (DHAP) released a new fact sheet...

    Aug 07, 2017 | Kim Rodgers

  • Project Inform: Safer Consumption Spaces in the U.S.: Uniting for a National Movement

    Project Inform released “Safer Consumption Spaces in the United States: Uniting for a National Movement.” This report stems from a...

    Jun 26, 2017 | Kim Rodgers

  • 2015 Viral Hepatitis Surveillance Report

    Last month, the Centers for Disease Control and Prevention (CDC) released preliminary viral hepatitis surveillance data. Now, the full...

    Jun 21, 2017 | Kim Rodgers

  • Issue Brief: Supervised Consumption Services

    amfAR, The Foundation for AIDS Research, released an issue brief on how supervised consumption services (SCS) — a public health...

    Jun 16, 2017 | Kim Rodgers

  • Join NASTAD’s Hepatitis Testing Partnership

    Within the first few years of initiating injection drug use, over half of people who inject drugs (PWID) will become infected with...

    Jun 08, 2017 | Kim Rodgers

  • Op-Ed: Interconnected, Intertwined, and Colliding: Co-occurring Epidemics of HIV,...

    In a recent blog, Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S Department of Health and...

    May 22, 2017 | Kim Rodgers

  • CDC: Viral Hepatitis Surveillance Report Marks Increases in Hep B, Hep C

    On May 11, 2017, the Centers for Disease Control and Prevention (CDC) announced new preliminary viral hepatitis surveillance data...

    May 12, 2017 | Kim Rodgers

  • Local Approaches to Eliminating Viral Hepatitis: Exploring the End Hep C SF...

    Approximately 3.5 million Americans are currently living with hepatitis C virus (HCV), yet only around half are aware of their...

    Jan 17, 2017 | Kim Rodgers

  • PEW: With Opioid Crisis, a Surge in Hepatitis C

    In a new “Stateline” article, Pew Charitable Trusts explores how the opioid epidemic is producing a surge in new hepatitis C infections. Below is an excerpt from the article: “Like the opioid epidemic that is driving it, the rate of new hepatitis C cases has spiked in the last five years. After declining for two […]

    Sep 01, 2017 | Kim Rodgers

    Fact Sheet: Reducing Harms from Injection Drug Use & Opioid Use Disorder with SSPs

    The Centers for Disease Control and Prevention’s (CDC’s) Division of HIV/AIDS Prevention (DHAP) released a new fact sheet on “Reducing Harms from Injection Drug Use & Opioid Use Disorder with Syringe Services Programs.” The fact sheet describes the components of a comprehensive syringe services program (SSP) and the related benefits to communities and public safety....

    Aug 07, 2017 | Kim Rodgers

    Project Inform: Safer Consumption Spaces in the U.S.: Uniting for a National Movement

    Project Inform released “Safer Consumption Spaces in the United States: Uniting for a National Movement.” This report stems from a think tank of the same name, held in Baltimore, MD on September 27-28, 2016, where a group of nearly 50 people who use drugs, advocates, policy experts and other public health and harm reduction workers […]

    Jun 26, 2017 | Kim Rodgers

    2015 Viral Hepatitis Surveillance Report

    Last month, the Centers for Disease Control and Prevention (CDC) released preliminary viral hepatitis surveillance data. Now, the full scope of that data is available in CDC’s 2015 Viral Hepatitis Surveillance Report. Highlights from the report include the following: The number of reported cases of hepatitis A increased 12.2% to 1,390 cases in 2015. After […]

    Jun 21, 2017 | Kim Rodgers

    Issue Brief: Supervised Consumption Services

    amfAR, The Foundation for AIDS Research, released an issue brief on how supervised consumption services (SCS) — a public health intervention that provide a hygienic space for people to use illicit drugs under the supervision of trained staff — may help reduce the risk of HIV/hepatitis C virus (HCV) transmission, prevent overdose fatalities, and connect PWUD with […]

    Jun 16, 2017 | Kim Rodgers

    Join NASTAD’s Hepatitis Testing Partnership

    Within the first few years of initiating injection drug use, over half of people who inject drugs (PWID) will become infected with hepatitis C virus (HCV). Preventing hepatitis transmission among PWID will require a comprehensive approach to harm reduction services including increased access to syringe services programs (SSPs), Medication Assisted Treatment (MAT), screening and diagnosis […]

    Jun 08, 2017 | Kim Rodgers

    Op-Ed: Interconnected, Intertwined, and Colliding: Co-occurring Epidemics of HIV, Viral Hepatitis, & Opioids

    In a recent blog, Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S Department of Health and Human Services, explored the relationship between injection drug use in the nation’s opioid epidemic, increases in hepatitis C infections, and regional outbreaks of HIV. Check out the blog and learn why continued coordination will be critical […]

    May 22, 2017 | Kim Rodgers

    CDC: Viral Hepatitis Surveillance Report Marks Increases in Hep B, Hep C

    On May 11, 2017, the Centers for Disease Control and Prevention (CDC) announced new preliminary viral hepatitis surveillance data showing that hepatitis B infections in the U.S. increased 20.7% in 2015 and the number of new hepatitis C infections reported to CDC nearly tripled between 2010 and 2015, reaching a 15-year high. CDC estimates that about […]

    May 12, 2017 | Kim Rodgers

    Local Approaches to Eliminating Viral Hepatitis: Exploring the End Hep C SF Initiative

    Approximately 3.5 million Americans are currently living with hepatitis C virus (HCV), yet only around half are aware of their infection. In 2013, hepatitis C-related mortality surpassed the total number of combined deaths from 60 other infectious diseases, including HIV and tuberculosis, reported to CDC. Fortunately, direct-acting antivirals have transformed the treatment landscape and now...

    Jan 17, 2017 | Kim Rodgers

    Back to Top